IRIS PubliCatt

De Stefano, Valerio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.465
EU - Europa 4.891
AS - Asia 913
SA - Sud America 42
AF - Africa 39
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 7
Totale 11.376
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.405
DE - Germania 1.263
SE - Svezia 1.091
IT - Italia 740
CN - Cina 647
UA - Ucraina 474
IE - Irlanda 353
FR - Francia 263
PL - Polonia 202
GB - Regno Unito 194
FI - Finlandia 128
IN - India 110
CA - Canada 37
RU - Federazione Russa 32
TR - Turchia 30
BE - Belgio 29
JP - Giappone 28
CI - Costa d'Avorio 27
ES - Italia 25
MX - Messico 21
AR - Argentina 20
SG - Singapore 20
IR - Iran 19
AT - Austria 18
AU - Australia 18
HK - Hong Kong 17
NL - Olanda 17
BR - Brasile 13
RO - Romania 13
CH - Svizzera 11
VN - Vietnam 8
CL - Cile 6
KR - Corea 6
A2 - ???statistics.table.value.countryCode.A2??? 5
IL - Israele 5
NO - Norvegia 5
CZ - Repubblica Ceca 4
HR - Croazia 4
HU - Ungheria 4
IQ - Iraq 4
MD - Moldavia 4
PT - Portogallo 4
BD - Bangladesh 3
DZ - Algeria 3
EE - Estonia 3
MY - Malesia 3
NG - Nigeria 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
DK - Danimarca 2
EU - Europa 2
GR - Grecia 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
TN - Tunisia 2
ZA - Sudafrica 2
BG - Bulgaria 1
EC - Ecuador 1
ID - Indonesia 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LT - Lituania 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TH - Thailandia 1
Totale 11.376
Salva come PNG Salva come JPEG
Città #
Chandler 1.178
Ashburn 449
Dublin 347
San Mateo 277
Jacksonville 276
Wilmington 211
Nanjing 187
Warsaw 178
Ann Arbor 161
Cattolica 160
Fairfield 147
Boston 143
Dearborn 143
Milan 121
New York 121
Woodbridge 121
Houston 108
Rome 102
Princeton 101
Redmond 95
Beijing 90
Lawrence 90
Marseille 90
Seattle 82
Redwood City 75
Nanchang 67
Los Angeles 60
Nürnberg 49
Chicago 47
Bremen 44
Norwalk 37
Hebei 35
Kunming 33
Mountain View 33
Cambridge 31
University Park 30
Boardman 29
Hangzhou 28
Abidjan 27
Shenyang 27
Zhengzhou 27
Detroit 26
Pune 26
Brussels 25
Lancaster 25
Leawood 25
Florence 24
Izmir 24
Jiaxing 24
Kraków 23
Munich 23
Tianjin 21
Changsha 20
Washington 19
London 17
Federal 16
Helsinki 16
Hong Kong 16
Mexico 16
Tobarra 16
Wayne 16
Guangzhou 12
San Diego 12
Andover 11
Falls Church 11
Hefei 11
Toronto 11
Vienna 11
Paris 10
San Francisco 10
Clearwater 9
Lanzhou 9
Pordenone 9
Shanghai 9
Augusta 8
Busto Arsizio 8
Jinan 8
Phoenix 8
Simi Valley 8
Monmouth Junction 7
Singapore 7
São Paulo 7
Edinburgh 6
Fremont 6
Padova 6
Perugia 6
Tokyo 6
Ypsilanti 6
Amsterdam 5
Atlanta 5
Changchun 5
Costa Mesa 5
Cuauhtémoc 5
Fuzhou 5
Hounslow 5
Kansas City 5
Kish 5
Napoli 5
Oslo 5
Verona 5
Totale 6.367
Salva come PNG Salva come JPEG
Nome #
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 277
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 257
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients. 251
Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old woman 225
Haemostatic alterations induced by treatment with asparaginases and clinical consequences 183
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 158
Risk factor and etiology analysis of ischemic stroke in young adult patients 135
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 130
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 129
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 122
Health Technology Assessment of genetic testing for susceptibility to Venous Thromboembolism in Italy 121
Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study). 117
Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect 116
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 116
A Case of Heparin Allergy With Good Tolerability to Fondaparinux During Pregnancy 113
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 106
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 105
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments 104
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms 104
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 102
Bisphosphonate therapy in multiple myeloma in preventing vertebral collapses: preliminary report 101
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 100
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 99
Factor V deficiency in pregnancy complicated by Rh immunization and placenta previa. A case report and review of the literature 97
Fondaparinux in pregnancy: Could it be a safe option? A review of the literature. 97
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 97
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 92
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 92
A Case of Heparin Allergy With Good Tolerability to Fondaparinux During Pregnancy. 91
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis 91
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 89
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 89
Venous thromboembolism in multiple myeloma 88
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 88
Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study 88
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease 87
The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia 86
Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation 86
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 85
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis 84
Prognostic Factors Associated With Progression of Smoldering Multiple Myeloma to Symptomatic Form 83
Autoimmune hemolytic anemia with gel-based immunohematology tests: neural network analysis 82
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 81
Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis) 81
A STARD-compliant prediction model for diagnosing thrombotic microangiopathies 79
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 76
Postpartum hemorrhage 75
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 75
Factor V deficiency in pregnancy complicated by Rh immunization and placenta previa. A case report and review of the literature 74
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 73
Inherited thrombophilia: treatment during pregnancy. 72
Ineherited Thrombophilia: treatment during pregnancy 72
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 72
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 71
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with Vitamin K antagonists 70
Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient With Unusual Extramedullary Presentation of Recurrent Multiple Myeloma 69
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia 68
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 68
A real-time integrated framework to support clinical decision making for covid-19 patients 68
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 66
Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups 63
Myeloid sarcoma with megakaryoblastic differentiation mimicking a sellar tumor 63
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 63
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 63
The Effects of Granulocyte Colony-Stimulating Factor in Patients with a Large Anterior Wall Acute Myocardial Infarction to Prevent Left Ventricular Remodeling: A 10-Year Follow-Up of the RIGENERA Study 62
IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapy 61
Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient with Unusual Extramedullary Presentation of Recurrent Multiple Myeloma 61
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 61
The interaction between small intestinal bacterial overgrowth and warfarin treatment 60
In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband 60
Evaluation of the prevalence of severe hyperhomocysteinemia in adult patients with thrombosis who underwent screening for thrombophilia 59
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 59
Obstetric complications and pregnancy-related venous thromboembolism: The effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation 58
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN 58
Platelet indices and glucose control in type 1 and type 2 diabetes mellitus: A case-control study 58
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 58
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 58
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study 57
Primary plasma cell leukemia: a retrospective multicenter study of 73 patients 56
Associations of antiphospholipid antibodies with splanchnic vein thrombosis: a systematic review with meta-analysis 55
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study 55
Abdominal thromboses of splanchnic, renal and ovarian veins 53
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia 53
Structural analysis of protein Z gene variants in patients with foetal losses 52
Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis 52
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 52
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 52
Ultrasound-Doppler diagnosis of Budd-Chiari syndrome 51
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 51
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 51
Management of elderly patients with immune thrombocytopenia: Real-world evidence from 451 patients older than 60 years 51
Pre-Exposure to Defibrotide Prevents Endothelial Cell Activation by Lipopolysaccharide: An Ingenuity Pathway Analysis 51
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 51
Rare thromboses of cerebral, splanchnic and upper-extremity veins. A narrative review 49
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax 49
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 49
Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers 49
Management of venous thromboembolism in myeloproliferative neoplasms 48
Platelet activation and inhibition in polycythemia vera and essential thrombocythemia. 47
Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases 47
Totale 8.479
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.636
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.636
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019183 0 0 0 0 0 0 0 0 0 0 142 41
2019/20201.537 278 83 73 160 99 161 115 36 89 81 223 139
2020/20211.241 56 135 32 132 156 75 137 29 145 47 271 26
2021/20221.682 130 103 29 76 101 29 24 260 82 108 321 419
2022/20233.394 513 479 295 490 206 381 179 229 371 91 110 50
2023/20241.359 74 510 57 78 78 236 108 96 32 61 29 0
Totale 11.641